[Various humoral factors regulating blood pressure in patients with hypertension during treatment by an impulse magnetic field].
Renin activity, aldosterone, prostaglandin (PGF2 alpha and PGB) and cyclic nucleotide levels and catecholamine excretion were measured in 165 essentially hypertensive patients exposed to therapeutic effects of "running" impulse magnetic field (RIMF). The correction of arterial blood pressure in RIMF-treated patients is shown to be mediated by BP-controlling humoral factors, the magnitude and direction of changes in levels and activity of biologically-active substances and hormones being determined by their respective baselines. A decrease of hyperfunction, as reflected in elevated hormonal production, and an increase of hypofunction were the most common therapeutic effect of RIMF exposure.
D000328:Adult; D000450:Aldosterone / Q000502:physiology*; D001794:Blood Pressure; D000242:Cyclic AMP / Q000502:physiology*; D006152:Cyclic GMP / Q000502:physiology*; D015237:Dinoprost; D005260:Female; D006706:Homeostasis; D006801:Humans; D006973:Hypertension / Q000503:physiopathology* / Q000628:therapy; D055909:Magnetic Field Therapy; D008297:Male; D008875:Middle Aged; D011460:Prostaglandins F / Q000502:physiology*; D012083:Renin / Q000502:physiology*
D011460:Prostaglandins F; D000450:Aldosterone; D015237:Dinoprost; D000242:Cyclic AMP; D012083:Renin; D006152:Cyclic GMP
Sostoianie nekotorykh gumoral'nykh faktorov, reguliruiushchikh arterial'noe davlenie, u bol'nykh gipertonicheskoĭ bolezn'iu pri lechenii impul'snym magnitnym polem.